Skip to main content
Fig. 6 | Journal of Translational Medicine

Fig. 6

From: Somatic mutation of DNAH genes implicated higher chemotherapy response rate in gastric adenocarcinoma patients

Fig. 6

Kaplan–Meier analyses of overall survival, progression-free survival, and chemotherapy-free survival in patients stratified by mutation frequency. The patients with gastric cancer tumors were dichotomously categorized based on mutation rate into the following two groups: high (highest one-third, n = 44) and low (bottom two-thirds, n = 88) mutation frequency. Subgroups were compared via the log-rank test

Back to article page